• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Antimicrob Agents Chemother. A conformational restriction in influenza A virus neuraminidase binding site by R152 caused the combinational effect of I

Giuseppe

Emeritus
[Source: Antimicrobial Agents and Chemotherapy, full page: (LINK). Abstract, edited.]


A conformational restriction in influenza A virus neuraminidase binding site by R152 caused the combinational effect of I222T with H274Y on oseltamivir resistance

Lan Huang 1,2, Yang Cao 3, Jianfang Zhou 1, Kun Qin 1, Wenfei Zhu 1, Yun Zhu 1, Lei Yang 1, Dayan Wang 1, Hong Wei 1# and Yuelong Shu 1#

Author Affiliations: <SUP>1</SUP>Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, China CDC, 155 Changbai Road, Beijing, 102206, PR China. <SUP>2</SUP>Children's Hospital of Chongqing Medical University, 136 Zhongshan second Road, Chongqing, 400014, PR China <SUP>3</SUP>Center of Growth, Metabolism and Aging, Key Laboratory of Bio-Resource and Eco-Environment, Ministry of Education, College of Life Sciences, Sichuan University, No.29 Wangjiang Road, Chengdu, 610064, PR China

Published ahead of print 23 December 2013, doi: 10.1128/AAC.01848-13 <CITE>AAC.01848-13 </CITE>
<CITE></CITE>
<CITE></CITE>
<CITE></CITE>ABSTRACT

The I222K, I222R and I222T substitutions in neuraminidase (NA) were currently found in clinically-derived 2009 pandemic H1N1 viruses with altered susceptibilities to NA inhibitors (NAIs). The effects of these substitutions together with the most frequently observed resistance related substitution, H274Y, on viral fitness and resistance mechanism were further investigated in this study. Reduced sensitivities to oseltamivir were observed in all three mutants. Furthermore, I222K and I222T substitutions had combinational effect of further increasing resistance in the presence of H274Y, which might result from a conformational restriction in NA binding-site. Especially, by using the molecular dynamics simulation, R152, the neighbor of T222, was observed to translate to a closer position to T222 and resulted in the narrowing down of binding pocket, which just subtended the residue substitution of H274Y. Moreover, significantly attenuated NA function and viral growth abilities were found in I222K+H274Y mutant, while I222T+H274Y mutant exhibited a slightly delayed growth but with similar peak viral titer as that of wild-type virus in MDCK cells. Relatively growth advantage of I222T mutant versus I222K and higher frequency of I222T emerging in N1 subtype influenza viruses raised the concerns to closely monitoring the dual substitutions of I222T and H274Y.


FOOTNOTES

# Correspondent footnote: Mailing address: National Institute for Viral Disease Control and Prevention, China CDC, 155 Changbai Road, Beijing, 102206, PR China. Dr. Yuelong Shu, Phone: +86-010-63580764. Fax: +86-010-63580764. E-mail: yshu@cnic.org.cn

# Mailing address: Children's Hospital of Chongqing Medical University, Chongqing, 400014, PR China., Dr. Hong Wei, Phone: +86-023-63635567 Email : waehong@yahoo.com

Copyright ? 2013, American Society for Microbiology. All Rights Reserved.


-
---------
 
Back
Top Bottom